SDC
Get informed when a big investor buys or sells
+ Follow| Market cap | $29.11 Million |
|---|---|
| Enterprise Value | $946.28 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.71 |
| Beta | 2.43 |
| Outstanding Shares | 389,665,923 |
| P/E Ratio | 0 |
|---|---|
| PEG | - |
| Price to Sales | 0.08 |
| Price to Book Ratio | -0.04 |
| Enterprise Value to Revenue | 2.16 |
| Enterprise Value to EBIT | -3.97 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 1 |
| Debt to Equity | 10.93 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
This powerful committee controls taxation and trade policy, directly influencing Smiledirectclub's corporate profitability, investment, and supply chain costs through tariffs and tax structures.
This committee regulates the FDA, which has direct oversight over Smiledirectclub's aligners as medical devices. Its influence on drug approvals and labor laws directly impacts the company's core operations and costs.
This committee oversees antitrust laws and intellectual property, which are crucial for Smiledirectclub's patents on aligners and teledentistry technology, as well as its market competitive position.
This committee's jurisdiction includes the FTC, which regulates consumer protection, advertising, and direct-to-consumer sales practices—all critical aspects of Smiledirectclub's business model.